Literature DB >> 21149826

Inflammation, immunity, and hypertension.

David G Harrison1, Tomasz J Guzik, Heinrich E Lob, Meena S Madhur, Paul J Marvar, Salim R Thabet, Antony Vinh, Cornelia M Weyand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21149826      PMCID： PMC3028593          DOI： 10.1161/HYPERTENSIONAHA.110.163576

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  91 in total

1.  Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation.

Authors:  Michael W Brands; Amy K L Banes-Berceli; Edward W Inscho; Hind Al-Azawi; Ashlyn J Allen; Hicham Labazi
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

2.  Lymphocyte responses exacerbate angiotensin II-dependent hypertension.

Authors:  Steven D Crowley; Young-Soo Song; Eugene E Lin; Robert Griffiths; Hyung-Suk Kim; Phillip Ruiz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-02-10       Impact factor: 3.619

3.  Different protective actions of losartan and tempol on the renal inflammatory response to acute sodium overload.

Authors:  María I Rosón; Silvana L Della Penna; Gabriel Cao; Susana Gorzalczany; Marcela Pandolfo; Jorge E Toblli; Belisario E Fernández
Journal:  J Cell Physiol       Date:  2010-07       Impact factor: 6.384

4.  Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension.

Authors:  Paul J Marvar; Salim R Thabet; Tomasz J Guzik; Heinrich E Lob; Louise A McCann; Connie Weyand; Frank J Gordon; David G Harrison
Journal:  Circ Res       Date:  2010-06-17       Impact factor: 17.367

5.  Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus.

Authors:  Marcia Venegas-Pont; Michaele B Manigrasso; Samira C Grifoni; Babbette B LaMarca; Christine Maric; Lorraine C Racusen; Porter H Glover; Allison V Jones; Heather A Drummond; Michael J Ryan
Journal:  Hypertension       Date:  2010-08-09       Impact factor: 10.190

6.  Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system.

Authors:  Heinrich E Lob; Paul J Marvar; Tomasz J Guzik; Shraya Sharma; Louise A McCann; Cornelia Weyand; Frank J Gordon; David G Harrison
Journal:  Hypertension       Date:  2009-12-14       Impact factor: 10.190

7.  Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis.

Authors:  Andreas Hermansson; Daniel F J Ketelhuth; Daniela Strodthoff; Marion Wurm; Emil M Hansson; Antonino Nicoletti; Gabrielle Paulsson-Berne; Göran K Hansson
Journal:  J Exp Med       Date:  2010-05-03       Impact factor: 14.307

8.  Immune regulation and vascular inflammation in genetic hypertension.

Authors:  Emilie C Viel; Catherine A Lemarié; Karim Benkirane; Pierre Paradis; Ernesto L Schiffrin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-31       Impact factor: 4.733

9.  Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

Authors:  Meena S Madhur; Heinrich E Lob; Louise A McCann; Yoichiro Iwakura; Yelena Blinder; Tomasz J Guzik; David G Harrison
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190

10.  Tempol ameliorates murine viral encephalomyelitis by preserving the blood-brain barrier, reducing viral load, and lessening inflammation.

Authors:  Maria Heloisa Tsuhako; Ohara Augusto; Edlaine Linares; Gerson Chadi; Selma Giorgio; Carlos A Pereira
Journal:  Free Radic Biol Med       Date:  2009-12-24       Impact factor: 7.376
View more
  324 in total

1.  Hypertensive renal injury is associated with gene variation affecting immune signaling.

Authors:  Michael C Braun; Stacy M Herring; Nisha Gokul; Monique Monita; Rebecca Bell; Yaming Zhu; Manuel L Gonzalez-Garay; Scott E Wenderfer; Peter A Doris
Journal:  Circ Cardiovasc Genet       Date:  2014-11-03

2.  Inflammatory cell markers as indicators of atherosclerotic renovascular disease.

Authors:  Stephen C Textor; Lilach O Lerman
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-12       Impact factor: 8.237

Review 3.  Long-term blood pressure control: is there a set-point in the brain?

Authors:  Yasuhiro Nishida; Megumi Tandai-Hiruma; Takehito Kemuriyama; Kohsuke Hagisawa
Journal:  J Physiol Sci       Date:  2012-05       Impact factor: 2.781

4.  Normal IgG downregulates the intracellular superoxide level and attenuates migration and permeability in human aortic endothelial cells isolated from a hypertensive patient.

Authors:  Xiuqing Wang; Qianyu Wang; Zhongjie Sun
Journal:  Hypertension       Date:  2012-07-09       Impact factor: 10.190

5.  Immune reactivity to heat shock protein 70 expressed in the kidney is cause of salt-sensitive hypertension.

Authors:  Héctor Pons; Atilio Ferrebuz; Yasmir Quiroz; Freddy Romero-Vasquez; Gustavo Parra; Richard J Johnson; Bernardo Rodriguez-Iturbe
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-24

6.  Resveratrol restored Nrf2 function, reduced renal inflammation, and mitigated hypertension in spontaneously hypertensive rats.

Authors:  Apurva A Javkhedkar; Yasmir Quiroz; Bernardo Rodriguez-Iturbe; Nosratola D Vaziri; Mustafa F Lokhandwala; Anees A Banday
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-03-11       Impact factor: 3.619

7.  Hypertensive crisis in children and adolescents.

Authors:  Tomáš Seeman; Gilad Hamdani; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2018-10-01       Impact factor: 3.714

Review 8.  Sex-specific immune modulation of primary hypertension.

Authors:  Kathryn Sandberg; Hong Ji; Meredith Hay
Journal:  Cell Immunol       Date:  2014-12-08       Impact factor: 4.868

9.  Systemic administration of pentoxifylline attenuates the development of hypertension in renovascular hypertensive rats.

Authors:  Anthony Setiadi; Willian S Korim; Clive N May; Song T Yao
Journal:  Hypertens Res       Date:  2020-02-14       Impact factor: 3.872

10.  Renal vein cytokine release as an index of renal parenchymal inflammation in chronic experimental renal artery stenosis.

Authors:  Alfonso Eirin; Xin Zhang; Xiang-Yang Zhu; Hui Tang; Kyra L Jordan; Joseph P Grande; Allan B Dietz; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Nephrol Dial Transplant       Date:  2013-10-03       Impact factor: 5.992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.